Bildgebung beim Prostatakarzinom

Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746–757 Beer AJ, Eiber M, Souvatzoglou M et al (2011) Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. Mol Imaging Biol 13:352–361 Bittencourt LK, Matos C, Coutinho AC Jr (2011) Diffusion-weighted magnetic resonance imaging in the upper abdomen: technical issues and clinical applications. Magn Reson Imaging Clin N Am 19:111–131 Bloch BN, Furman-Haran E, Helbich TH et al (2007) Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging – initial results. Radiology 245:176–185 Chen Z, Penet M-F, Nimmagadda S et al (2011) Theranostic imaging of metastatic prostate cancer. Proc Intl Soc Mag Reson Med 19:448 Cornfeld DM, Weinreb JC (2007) MR imaging of the prostate: 1.5 T versus 3 T. Magn Reson Imaging Clin N Am 15:433–448 Delongchamps NB, Peyromaure M, Schull A et al (2013) Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol 189:493–499 Desouza NM, Riches SF, Vanas NJ et al (2008) Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 63:774–782 Deutsche Gesellschaft für Urologie (2011) Prostatakarzinom: Früherkennung, Diagnose und Therapie der verschiedenen Stadien.. AWMF-Register: Nummer 043-022OL. http://awmf.org Doo KW, Sung DJ, Park BJ et al (2012) Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI. Eur Radiol 22:1812–1819 Franiel T, Stephan C, Erbersdobler A et al (2011) Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding – multiparametric MR imaging for detection and biopsy planning. Radiology 259:162–172 Fueger BJ, Helbich TH, Schernthaner M et al (2011) Diagnose importance of multiparametric magnetic resonance tomography for prostate cancer. Radiologe 51:947–954 Futterer JJ, Engelbrecht MR, Jager GJ et al (2007) Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17:1055–1065 Futterer JJ, Heijmink SW, Scheenen TW et al (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241:449–458 Ganswindt U, Schilling D, Muller AC et al (2011) Distribution of prostate sentinel nodes: a SPECT-derived anatomic atlas. Int J Radiat Oncol Biol Phys 79:1364–1372 Haider MA, Van Der Kwast TH, Tanguay J et al (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189:323–328 Heesakkers RA, Hovels AM, Jager GJ et al (2008) MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 9:850–856 Heidenreich A, Bellmunt J, Bolla M et al (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59:61–71 Hovels AM, Heesakkers RA, Adang EM et al (2008) The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63:387–395 Itou Y, Nakanishi K, Narumi Y et al (2011) Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer? J Magn Reson Imaging 33:167–172 Mazaheri Y, Hricak H, Fine SW et al (2009) Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 252:449–457 Meijer HJ, Fortuin AS, Van Lin EN et al (2013) Geographical distribution of lymph node metastases on MR lymphography in prostate cancer patients. Radiother Oncol 106:59–63 Mullerad M, Hricak H, Kuroiwa K et al (2005) Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174:2158–2163 Outwater EK, Petersen RO, Siegelman ES et al (1994) Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology 193:333–339 Padhani AR, Harvey CJ, Cosgrove DO (2005) Angiogenesis imaging in the management of prostate cancer. Nat Clin Pract Urol 2:596–607 Ren J, Huan Y, Wang H et al (2008) Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases. Abdom Imaging 33:724–728 Rischke HC, Schafer AO, Nestle U et al (2012) Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil. Radiat Oncol 7:185 Sato C, Naganawa S, Nakamura T et al (2005) Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21:258–262 Schouten MG, Nagel NA, HambrockT et al (2011) Apparent diffusion coefficient values during magnetic resonance-guided biopsy of the prostate: correlation with histological results. Proc Intl Soc Mag Reson Med 19:1052 Selnaes KM, Heerschap A, Jensen LR et al (2012) Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology. Invest Radiol 47:624–633 Tamada T, Sone T, Jo Y et al (2008) Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 28:720–726 Turkbey B, Mani H, Shah V et al (2011) Multiparametric 3 T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 186:1818–1824 Turkbey B, Pinto PA, Mani H et al (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection – histopathologic correlation. Radiology 255:89–99 Turkbey B, Shah VP, Pang Y et al (2011) Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 258:488–495 Weidner AM, Van Lin EN, Dinter DJ et al (2011) Ferumoxtran-10 MR lymphography for target definition and follow-up in a patient undergoing image-guided, dose-escalated radiotherapy of lymph nodes upon PSA relapse. Strahlenther Onkol 187:206–212 Westphalen AC, Coakley FV, Roach M III et al (2010) Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection. Radiology 256:485–492 Xylinas E, Yates DR, Renard-Penna R et al (2011) Role of pelvic phased array magnetic resonance imaging in staging of prostate cancer specifically in patients diagnosed with clinically locally advanced tumours by digital rectal examination. World J Urol. DOI 10.1007/s00345-011-0811-z